'
Epigral held a conference call on 04 August 2025 to discuss the results for the quarter ended June 2025 and way forward. Mr. Maulik Patel – Chairman and Managing Director, Mr. Kaushal Soparkar – Executive Director, Mr. Sanjay Jain – Chief Financial Officer and Mr. Milind Kotecha – Investor Relations and Strategy of the company addressed the call.
Highlights of the Concall
- The company mentioned that the chemical industry is on the growth path but a slower pace. Volatility was witnessed in Q1 FY26 and is expected to continue on account of uncertainty on tariffs from the US and also because of the geopolitical situation. However, domestic demand remains strong compared to the global demand.
- The company reported a revenue degrowth of around 6% in Q1FY26 mainly on account of decreasing volume due to the maintenance work happening at the plant which will end by end of this quarter. It expect optimum capacity utilization to start by end of Q2FY26 beca...
Pleaselogin & subscribe to view the full report.
More Reports
|
|